Tissue Testing Technologies LLC

États‑Unis d’Amérique

Retour au propriétaire

1-7 de 7 pour Tissue Testing Technologies LLC Trier par
Recheche Texte
Affiner par
Date
2023 2
2022 2
2021 1
Avant 2021 2
Classe IPC
A01N 1/02 - Conservation de parties vivantes 5
A01N 59/16 - Métaux lourdsLeurs composés 1
A61L 27/36 - Matériaux pour prothèses ou pour revêtement de prothèses contenant des constituants de constitution indéterminée ou leurs produits réactionnels 1
C12M 1/12 - Appareillage pour l'enzymologie ou la microbiologie avec des moyens de stérilisation, filtration ou dialyse 1
C12M 1/32 - Inoculateur ou échantillonneur du type à champs multiples ou en continu 1
Voir plus
Résultats pour  brevets

1.

PRESERVATION OF NATURAL AND BIONENGINEERED TISSUES AND METHODS OF STORING AND TRANSPORT

      
Numéro d'application US2022049930
Numéro de publication 2023/086664
Statut Délivré - en vigueur
Date de dépôt 2022-11-15
Date de publication 2023-05-19
Propriétaire TISSUE TESTING TECHNOLOGIES LLC (USA)
Inventeur(s)
  • Campbell, Lia H.
  • Brockbank, Kelvin G.M.

Abrégé

Described herein are methods for preserving biomaterials by vitrification while reducing or preventing the loss of viability associated with conventional preservation methods. Also described herein are cassettes and methods for using these cassettes for cryopreserving biomaterials (e.g., a bioengineered construct or natural tissue sample).

Classes IPC  ?

  • A01N 1/02 - Conservation de parties vivantes

2.

CASSETTE FOR PRESERVATION OF NATURAL AND BIOENGINEERED TISSUES

      
Numéro d'application US2022049939
Numéro de publication 2023/086668
Statut Délivré - en vigueur
Date de dépôt 2022-11-15
Date de publication 2023-05-19
Propriétaire TISSUE TESTING TECHNOLOGIES LLC (USA)
Inventeur(s)
  • Campbell, Lia H.
  • Wright, Gregory J.
  • Greene, Elizabeth
  • Brockbank, Kelvin G.M.

Abrégé

Described herein are cassettes and methods for using these cassettes for cryopreserving biomaterials (e.g., a bioengineered construct or natural tissue sample) by vitrification while reducing or preventing the loss of viability associated with conventional preservation methods.

Classes IPC  ?

  • C12M 1/32 - Inoculateur ou échantillonneur du type à champs multiples ou en continu
  • C12M 3/00 - Appareillage pour la culture de tissus, de cellules humaines, animales ou végétales, ou de virus
  • C12M 1/12 - Appareillage pour l'enzymologie ou la microbiologie avec des moyens de stérilisation, filtration ou dialyse

3.

PRESERVATION METHODS USING TREHALOSE WITH OTHER CRYOPROTECTANTS BEING ABSENT FROM THE CRYOPRESERVATION PROTOCOL

      
Numéro d'application US2022027248
Numéro de publication 2022/235552
Statut Délivré - en vigueur
Date de dépôt 2022-05-02
Date de publication 2022-11-10
Propriétaire TISSUE TESTING TECHNOLOGIES LLC (USA)
Inventeur(s)
  • Brockbank, Kelvin G.M.
  • Campbell, Lia H.

Abrégé

Cellular material containing living cells is preserved by combining the cellular material with a cryoprotectant formulation/medium/solution containing an effective amount of trehalose (in the absence of DMSO and/or any other added cryoprotectants) during a cryopreservation protocol. That is, the cryopreservation protocol is free of cryoprotectant other than trehalose, and the cryopreservation protocol includes: exposing the cellular material to a cryoprotectant formulation containing an effective amount of the trehalose to act as a cryoprotectant, cooling the cellular material at a cooling rate in the range of from ‑3°C/minute to -50°C/minute to a predetermined temperature below -20°C, and obtaining a cryopreserved cellular material that has been warmed.

Classes IPC  ?

  • A01N 1/02 - Conservation de parties vivantes

4.

MINIMIZING IMMUNOGENICITY OF DECELLULARIZED TISSUES

      
Numéro d'application US2021055788
Numéro de publication 2022/087089
Statut Délivré - en vigueur
Date de dépôt 2021-10-20
Date de publication 2022-04-28
Propriétaire TISSUE TESTING TECHNOLOGIES LLC (USA)
Inventeur(s) Brockbank, Kelvin Gm

Abrégé

A method for preserving and reducing the immunogenicity of a tissue, the method including obtaining a first tissue, the first tissue being a wild type tissue or genetically modified tissue; forming a second tissue by immersing the first tissue in a first solution having a cryoprotectant concentration of at least about 75% by weight for at least one hour to kill and lyse the cells of the first tissue; forming a third tissue by removing residual cell materials of the second tissue, the residual cell materials of the second tissue being removed by subjecting the second tissue to decellularization in a bioreactor; and subjecting the third tissue to ice-free cryopreservation.

Classes IPC  ?

  • A61L 27/36 - Matériaux pour prothèses ou pour revêtement de prothèses contenant des constituants de constitution indéterminée ou leurs produits réactionnels

5.

ICE-FREE VITRIFICATION AND NANO-WARMING OF LARGE TISSUE SAMPLES

      
Numéro d'application US2020058843
Numéro de publication 2021/091984
Statut Délivré - en vigueur
Date de dépôt 2020-11-04
Date de publication 2021-05-14
Propriétaire TISSUE TESTING TECHNOLOGIES LLC (USA)
Inventeur(s)
  • Brockbank, Kelvin Gm
  • Chen, Zhen Zhen

Abrégé

Large volume cellular material may be preserved by combining the cellular material with a cryoprotectant formulation/medium/solution containing at least one mNP and then subjecting the cellular material to a vitrification preservation protocol including nanowarming. This preservation method is particularly effective for cartilage tissues and large blood vessels, and includes, for example, exposing the cellular material to a high concentration cryoprotectant formulation containing at least 0.5 mg/mL Fe mNPs, subjecting the cellular material to a preservation protocol in which ice-induced damage to the cellular material does not occur, and obtaining a cryopreserved cellular material that has been nanowarmed; wherein metabolic activity of the nanowarmed tissue is fully recovered to control values within two days of being rewarmed.

Classes IPC  ?

6.

ICE-FREE PRESERVATION OF LARGE VOLUME TISSUE SAMPLES FOR VIABLE, FUNCTIONAL TISSUE BANKING

      
Numéro d'application US2017067060
Numéro de publication 2018/118799
Statut Délivré - en vigueur
Date de dépôt 2017-12-18
Date de publication 2018-06-28
Propriétaire TISSUE TESTING TECHNOLOGIES LLC (USA)
Inventeur(s)
  • Brockbank, Kelvin, Gm.
  • Campbell, Lia, H.

Abrégé

Large volume cellular material may be preserved by combining the cellular material with a cryoprotectant formulation/medium/solution containing at least one sugar and then subjecting the cellular material to a vitrification preservation protocol.

Classes IPC  ?

  • A01N 1/02 - Conservation de parties vivantes

7.

ENHANCEMENT OF CELL CRYOPRESERVATION WITH GLYCOLIPIDS

      
Numéro d'application US2017043090
Numéro de publication 2018/017843
Statut Délivré - en vigueur
Date de dépôt 2017-07-20
Date de publication 2018-01-25
Propriétaire TISSUE TESTING TECHNOLOGIES LLC (USA)
Inventeur(s)
  • Campbell, Lia H.
  • Brockbank, Kelvin G. M.

Abrégé

The application relates to a method for preserving living cellular material, comprising: exposing a cellular material to medium containing at least one glycolipid and a cryoprotectant for a predetermined amount of time; and after the exposure, subjecting the cellular material to a preservation protocol comprising cryopreservation at a cryopreservation temperature of about -80°C or less.

Classes IPC  ?

  • A01N 1/02 - Conservation de parties vivantes